Related Experiment Video
Updated: Mar 23, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses
Morena Pappalardo1, Miguel Juliá1, Mark J Howard1
1Centre for Molecular Processing and School of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, UK.
Reston viruses are unique Ebolaviruses non-pathogenic to humans. Specific amino acid changes in viral proteins may explain this difference, but could also lead to future human pathogenicity.
Area of Science:
- Virology
- Molecular Biology
- Structural Biology
Background:
- Reston viruses are the sole Ebolaviruses lacking human pathogenicity.
- Understanding the molecular basis for this difference is crucial for predicting viral evolution and emergence.
Purpose of the Study:
- To identify specific amino acid residues differentiating Reston viruses from pathogenic Ebolaviruses.
- To investigate the functional and structural implications of these specificity-determining positions (SDPs).
Main Methods:
- Analysis of 196 Ebolavirus genomes to identify SDPs across all nine viral proteins.
- Structural analysis of identified SDPs to assess their potential functional impact.
- Focus on Ebolavirus proteins VP40 and VP24.
Main Results:
- SDPs distinguishing Reston viruses from pathogenic Ebolaviruses were identified in all nine proteins.
- VP40 SDPs (P85T, Q245P) were found to alter octamer formation and protein structure/function.
- VP24 SDPs (T131S, M136L, Q139R) may impair binding to human karyopherin alpha5, affecting interferon signaling.
Conclusions:
- Specific SDPs in VP40 and VP24 likely explain differences in human pathogenicity.
- Alterations in VP24 are critical for host adaptation, and minimal differences suggest potential for human pathogenic Reston virus emergence.
- Given Reston virus circulation in pigs and potential for airborne transmission, emergence is a significant concern.
More Related Videos
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Related Concept Videos
Multi-species Conserved Sequences
Although the genome of each species varies greatly from each other, a few sequences are highly conserved. Such conserved...
Viral Mutations
Leaky Scanning
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Cross-reactivity